Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
1.66 EUR | -1.19% | -4.05% | +5.40% |
20/05 | Herantis Pharma Submits Clinical Trial Application for A Phase 1B Clinical Trial of Her-096 | CI |
06/03 | Herantis Pharma Oyj Reports Earnings Results for the Full Year Ended December 31, 2023 | CI |
Annual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
+5.40% | 3.58Cr | |
+18.15% | 12TCr | |
+18.02% | 11TCr | |
+5.07% | 2.29TCr | |
-12.75% | 2.22TCr | |
-9.86% | 1.7TCr | |
-14.97% | 1.69TCr | |
-39.94% | 1.69TCr | |
+2.80% | 1.36TCr | |
+27.39% | 1.16TCr |
- Stock Market
- Equities
- HRTIS Stock
- News Herantis Pharma Oyj
- Herantis Pharma Plc Announces Executive Appointments